Pharma & Healthcare
Global Sevoflurane Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 301512
- Pages: 140
- Figures: 127
- Views: 1
In 2024, the global market size of Sevoflurane was estimated to be worth US$ 1195 million and is forecast to reach approximately US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sevoflurane, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevoflurane.
The Sevoflurane market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sevoflurane market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sevoflurane manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Hengrui
Baxter
Maruishi
AbbVie
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma
Segment by Type
Generic Drug
Original Drug
Segment by Application
Hospital
Clinics
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Sevoflurane in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Sevoflurane manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sevoflurane sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sevoflurane, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevoflurane.
The Sevoflurane market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sevoflurane market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sevoflurane manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Hengrui
Baxter
Maruishi
AbbVie
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma
Segment by Type
Generic Drug
Original Drug
Segment by Application
Hospital
Clinics
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Sevoflurane in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Sevoflurane manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sevoflurane sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Sevoflurane Product Introduction
1.2 Market by Type
1.2.1 Global Sevoflurane Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Market by Application
1.3.1 Global Sevoflurane Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sevoflurane Market Size Estimates and Forecasts
2.1.1 Global Sevoflurane Revenue 2020-2031
2.1.2 Global Sevoflurane Sales 2020-2031
2.2 Sevoflurane Market Size by Region: 2024 Versus 2031
2.3 Sevoflurane Sales by Region (2020-2031)
2.3.1 Global Sevoflurane Sales by Region: 2020-2025
2.3.2 Global Sevoflurane Sales Forecast by Region (2026-2031)
2.3.3 Global Sevoflurane Sales Market Share by Region (2020-2031)
2.4 Sevoflurane Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Sevoflurane Revenue by Region: 2020-2025
2.4.2 Global Sevoflurane Revenue Forecast by Region (2026-2031)
2.4.3 Global Sevoflurane Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Sevoflurane Sales by Type (2020-2031)
3.1.1.1 Global Sevoflurane Sales Volume by Type (2020-2031)
3.1.1.2 Global Sevoflurane Sales Market Share by Type (2020-2031)
3.1.2 Global Sevoflurane Revenue by Type (2020-2031)
3.1.2.1 Global Sevoflurane Revenue by Type (2020-2031)
3.1.2.2 Global Sevoflurane Revenue Market Share by Type (2020-2031)
3.1.3 Sevoflurane Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Sevoflurane Sales by Application (2020-2031)
3.2.1.1 Global Sevoflurane Sales Volume by Application (2020-2031)
3.2.1.2 Global Sevoflurane Sales Market Share by Application (2020-2031)
3.2.2 Global Sevoflurane Revenue by Application (2020-2031)
3.2.2.1 Global Sevoflurane Revenue by Application (2020-2031)
3.2.2.2 Global Sevoflurane Revenue Market Share by Application (2020-2031)
3.2.3 Sevoflurane Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Generic Drug of Sevoflurane Revenue Market Share by Application
3.3.2 Original Drug of Sevoflurane Revenue Market Share by Application
4 Global Sevoflurane by Manufacturers
4.1 Global Top Sevoflurane Manufacturers by Sales (2020-2025)
4.1.1 Global Sevoflurane Sales by Manufacturer (2020-2025)
4.1.2 Global Sevoflurane Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Sevoflurane Manufacturers by Revenue (2020-2025)
4.2.1 Global Sevoflurane Revenue by Manufacturer (2020-2025)
4.2.2 Global Sevoflurane Revenue Share by Manufacturer (2020-2025)
4.3 Global Sevoflurane Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Sevoflurane Manufacturers Covered: Ranking by Revenue
4.4.2 Global Sevoflurane Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Sevoflurane Manufacturing Base Distribution, Product Type
4.5.1 Sevoflurane Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Sevoflurane Market
4.5.3 Manufacturers Sevoflurane Product Type and Application
4.5.4 Generic Drug Market Sales of Sevoflurane by Manufacturer
4.5.5 Original Drug Market Sales of Sevoflurane by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Hengrui
5.1.1 Hengrui Company Information
5.1.2 Hengrui Description, Business Overview
5.1.3 Hengrui Sevoflurane Products Offered
5.1.4 Hengrui Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Hengrui Sevoflurane Sales by Product in 2024
5.1.6 Hengrui Sevoflurane Sales by Application in 2024
5.1.7 Hengrui Sevoflurane Sales by Geographic Area in 2024
5.1.8 Hengrui Recent Developments
5.2 Baxter
5.2.1 Baxter Company Information
5.2.2 Baxter Description, Business Overview
5.2.3 Baxter Sevoflurane Products Offered
5.2.4 Baxter Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Baxter Sevoflurane Sales by Product in 2024
5.2.6 Baxter Sevoflurane Sales by Application in 2024
5.2.7 Baxter Sevoflurane Sales by Geographic Area in 2024
5.2.8 Baxter Recent Developments
5.3 Maruishi
5.3.1 Maruishi Company Information
5.3.2 Maruishi Description, Business Overview
5.3.3 Maruishi Sevoflurane Products Offered
5.3.4 Maruishi Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Maruishi Sevoflurane Sales by Product in 2024
5.3.6 Maruishi Sevoflurane Sales by Application in 2024
5.3.7 Maruishi Sevoflurane Sales by Geographic Area in 2024
5.3.8 Maruishi Recent Developments
5.4 AbbVie
5.4.1 AbbVie Company Information
5.4.2 AbbVie Description, Business Overview
5.4.3 AbbVie Sevoflurane Products Offered
5.4.4 AbbVie Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.4.5 AbbVie Sevoflurane Sales by Product in 2024
5.4.6 AbbVie Sevoflurane Sales by Application in 2024
5.4.7 AbbVie Sevoflurane Sales by Geographic Area in 2024
5.4.8 AbbVie Recent Developments
5.5 Piramal
5.5.1 Piramal Company Information
5.5.2 Piramal Description, Business Overview
5.5.3 Piramal Sevoflurane Products Offered
5.5.4 Piramal Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Piramal Sevoflurane Sales by Product in 2024
5.5.6 Piramal Sevoflurane Sales by Application in 2024
5.5.7 Piramal Sevoflurane Sales by Geographic Area in 2024
5.5.8 Piramal Recent Developments
5.6 Viatris
5.6.1 Viatris Company Information
5.6.2 Viatris Description, Business Overview
5.6.3 Viatris Sevoflurane Products Offered
5.6.4 Viatris Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Viatris Sevoflurane Sales by Product in 2024
5.6.6 Viatris Sevoflurane Sales by Application in 2024
5.6.7 Viatris Sevoflurane Sales by Geographic Area in 2024
5.6.8 Viatris Recent Developments
5.7 PT Novell Pharmaceutical
5.7.1 PT Novell Pharmaceutical Company Information
5.7.2 PT Novell Pharmaceutical Description, Business Overview
5.7.3 PT Novell Pharmaceutical Sevoflurane Products Offered
5.7.4 PT Novell Pharmaceutical Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.7.5 PT Novell Pharmaceutical Sevoflurane Sales by Product in 2024
5.7.6 PT Novell Pharmaceutical Sevoflurane Sales by Application in 2024
5.7.7 PT Novell Pharmaceutical Sevoflurane Sales by Geographic Area in 2024
5.7.8 PT Novell Pharmaceutical Recent Developments
5.8 Lunan Pharma
5.8.1 Lunan Pharma Company Information
5.8.2 Lunan Pharma Description, Business Overview
5.8.3 Lunan Pharma Sevoflurane Products Offered
5.8.4 Lunan Pharma Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Lunan Pharma Sevoflurane Sales by Product in 2024
5.8.6 Lunan Pharma Sevoflurane Sales by Application in 2024
5.8.7 Lunan Pharma Sevoflurane Sales by Geographic Area in 2024
5.8.8 Lunan Pharma Recent Developments
6 North America
6.1 North America Sevoflurane Market Size YoY Growth 2020-2031
6.2 North America Sevoflurane Market Facts & Figures by Country
6.2.1 North America Sevoflurane Sales by Country (2020-2031)
6.2.2 North America Sevoflurane Revenue by Country (2020-2031)
6.3 North America Sevoflurane Sales by Type (2020-2025)
6.4 North America Sevoflurane Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Sevoflurane Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Sevoflurane Market Facts & Figures by Region
7.2.1 Asia-Pacific Sevoflurane Sales by Region (2020-2031)
7.2.2 Asia-Pacific Sevoflurane Revenue by Region (2020-2031)
7.3 Asia-Pacific Sevoflurane Sales by Type (2020-2025)
7.4 Asia-Pacific Sevoflurane Sales by Application (2020-2025)
8 Europe
8.1 Europe Sevoflurane Market Size YoY Growth 2020-2031
8.2 Europe Sevoflurane Market Facts & Figures by Country
8.2.1 Europe Sevoflurane Sales by Country (2020-2031)
8.2.2 Europe Sevoflurane Revenue by Country (2020-2031)
8.3 Europe Sevoflurane Sales by Type (2020-2025)
8.4 Europe Sevoflurane Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Sevoflurane Market Size YoY Growth 2020-2031
9.2 Latin America Sevoflurane Market Facts & Figures by Country
9.2.1 Latin America Sevoflurane Sales by Country (2020-2031)
9.2.2 Latin America Sevoflurane Revenue by Country (2020-2031)
9.3 Latin America Sevoflurane Sales by Type (2020-2025)
9.4 Latin America Sevoflurane Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Sevoflurane Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Sevoflurane Market Facts & Figures by Country
10.2.1 Middle East and Africa Sevoflurane Sales by Country (2020-2031)
10.2.2 Middle East and Africa Sevoflurane Revenue by Country (2020-2031)
10.3 Middle East and Africa Sevoflurane Sales by Type (2020-2025)
10.4 Middle East and Africa Sevoflurane Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Sevoflurane Supply Chain Analysis
11.2 Sevoflurane Key Raw Materials and Upstream Suppliers
11.3 Sevoflurane Clients Analysis
11.4 Sevoflurane Sales Channel and Sales Model Analysis
11.4.1 Sevoflurane Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Sevoflurane Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Sevoflurane Distributors
12 Sevoflurane Market Dynamics
12.1 Sevoflurane Industry Trends
12.2 Sevoflurane Market Drivers
12.3 Sevoflurane Market Challenges
12.4 Sevoflurane Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Sevoflurane Product Introduction
1.2 Market by Type
1.2.1 Global Sevoflurane Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Market by Application
1.3.1 Global Sevoflurane Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sevoflurane Market Size Estimates and Forecasts
2.1.1 Global Sevoflurane Revenue 2020-2031
2.1.2 Global Sevoflurane Sales 2020-2031
2.2 Sevoflurane Market Size by Region: 2024 Versus 2031
2.3 Sevoflurane Sales by Region (2020-2031)
2.3.1 Global Sevoflurane Sales by Region: 2020-2025
2.3.2 Global Sevoflurane Sales Forecast by Region (2026-2031)
2.3.3 Global Sevoflurane Sales Market Share by Region (2020-2031)
2.4 Sevoflurane Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Sevoflurane Revenue by Region: 2020-2025
2.4.2 Global Sevoflurane Revenue Forecast by Region (2026-2031)
2.4.3 Global Sevoflurane Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Sevoflurane Sales by Type (2020-2031)
3.1.1.1 Global Sevoflurane Sales Volume by Type (2020-2031)
3.1.1.2 Global Sevoflurane Sales Market Share by Type (2020-2031)
3.1.2 Global Sevoflurane Revenue by Type (2020-2031)
3.1.2.1 Global Sevoflurane Revenue by Type (2020-2031)
3.1.2.2 Global Sevoflurane Revenue Market Share by Type (2020-2031)
3.1.3 Sevoflurane Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Sevoflurane Sales by Application (2020-2031)
3.2.1.1 Global Sevoflurane Sales Volume by Application (2020-2031)
3.2.1.2 Global Sevoflurane Sales Market Share by Application (2020-2031)
3.2.2 Global Sevoflurane Revenue by Application (2020-2031)
3.2.2.1 Global Sevoflurane Revenue by Application (2020-2031)
3.2.2.2 Global Sevoflurane Revenue Market Share by Application (2020-2031)
3.2.3 Sevoflurane Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Generic Drug of Sevoflurane Revenue Market Share by Application
3.3.2 Original Drug of Sevoflurane Revenue Market Share by Application
4 Global Sevoflurane by Manufacturers
4.1 Global Top Sevoflurane Manufacturers by Sales (2020-2025)
4.1.1 Global Sevoflurane Sales by Manufacturer (2020-2025)
4.1.2 Global Sevoflurane Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Sevoflurane Manufacturers by Revenue (2020-2025)
4.2.1 Global Sevoflurane Revenue by Manufacturer (2020-2025)
4.2.2 Global Sevoflurane Revenue Share by Manufacturer (2020-2025)
4.3 Global Sevoflurane Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Sevoflurane Manufacturers Covered: Ranking by Revenue
4.4.2 Global Sevoflurane Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Sevoflurane Manufacturing Base Distribution, Product Type
4.5.1 Sevoflurane Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Sevoflurane Market
4.5.3 Manufacturers Sevoflurane Product Type and Application
4.5.4 Generic Drug Market Sales of Sevoflurane by Manufacturer
4.5.5 Original Drug Market Sales of Sevoflurane by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Hengrui
5.1.1 Hengrui Company Information
5.1.2 Hengrui Description, Business Overview
5.1.3 Hengrui Sevoflurane Products Offered
5.1.4 Hengrui Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Hengrui Sevoflurane Sales by Product in 2024
5.1.6 Hengrui Sevoflurane Sales by Application in 2024
5.1.7 Hengrui Sevoflurane Sales by Geographic Area in 2024
5.1.8 Hengrui Recent Developments
5.2 Baxter
5.2.1 Baxter Company Information
5.2.2 Baxter Description, Business Overview
5.2.3 Baxter Sevoflurane Products Offered
5.2.4 Baxter Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Baxter Sevoflurane Sales by Product in 2024
5.2.6 Baxter Sevoflurane Sales by Application in 2024
5.2.7 Baxter Sevoflurane Sales by Geographic Area in 2024
5.2.8 Baxter Recent Developments
5.3 Maruishi
5.3.1 Maruishi Company Information
5.3.2 Maruishi Description, Business Overview
5.3.3 Maruishi Sevoflurane Products Offered
5.3.4 Maruishi Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Maruishi Sevoflurane Sales by Product in 2024
5.3.6 Maruishi Sevoflurane Sales by Application in 2024
5.3.7 Maruishi Sevoflurane Sales by Geographic Area in 2024
5.3.8 Maruishi Recent Developments
5.4 AbbVie
5.4.1 AbbVie Company Information
5.4.2 AbbVie Description, Business Overview
5.4.3 AbbVie Sevoflurane Products Offered
5.4.4 AbbVie Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.4.5 AbbVie Sevoflurane Sales by Product in 2024
5.4.6 AbbVie Sevoflurane Sales by Application in 2024
5.4.7 AbbVie Sevoflurane Sales by Geographic Area in 2024
5.4.8 AbbVie Recent Developments
5.5 Piramal
5.5.1 Piramal Company Information
5.5.2 Piramal Description, Business Overview
5.5.3 Piramal Sevoflurane Products Offered
5.5.4 Piramal Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Piramal Sevoflurane Sales by Product in 2024
5.5.6 Piramal Sevoflurane Sales by Application in 2024
5.5.7 Piramal Sevoflurane Sales by Geographic Area in 2024
5.5.8 Piramal Recent Developments
5.6 Viatris
5.6.1 Viatris Company Information
5.6.2 Viatris Description, Business Overview
5.6.3 Viatris Sevoflurane Products Offered
5.6.4 Viatris Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Viatris Sevoflurane Sales by Product in 2024
5.6.6 Viatris Sevoflurane Sales by Application in 2024
5.6.7 Viatris Sevoflurane Sales by Geographic Area in 2024
5.6.8 Viatris Recent Developments
5.7 PT Novell Pharmaceutical
5.7.1 PT Novell Pharmaceutical Company Information
5.7.2 PT Novell Pharmaceutical Description, Business Overview
5.7.3 PT Novell Pharmaceutical Sevoflurane Products Offered
5.7.4 PT Novell Pharmaceutical Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.7.5 PT Novell Pharmaceutical Sevoflurane Sales by Product in 2024
5.7.6 PT Novell Pharmaceutical Sevoflurane Sales by Application in 2024
5.7.7 PT Novell Pharmaceutical Sevoflurane Sales by Geographic Area in 2024
5.7.8 PT Novell Pharmaceutical Recent Developments
5.8 Lunan Pharma
5.8.1 Lunan Pharma Company Information
5.8.2 Lunan Pharma Description, Business Overview
5.8.3 Lunan Pharma Sevoflurane Products Offered
5.8.4 Lunan Pharma Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Lunan Pharma Sevoflurane Sales by Product in 2024
5.8.6 Lunan Pharma Sevoflurane Sales by Application in 2024
5.8.7 Lunan Pharma Sevoflurane Sales by Geographic Area in 2024
5.8.8 Lunan Pharma Recent Developments
6 North America
6.1 North America Sevoflurane Market Size YoY Growth 2020-2031
6.2 North America Sevoflurane Market Facts & Figures by Country
6.2.1 North America Sevoflurane Sales by Country (2020-2031)
6.2.2 North America Sevoflurane Revenue by Country (2020-2031)
6.3 North America Sevoflurane Sales by Type (2020-2025)
6.4 North America Sevoflurane Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Sevoflurane Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Sevoflurane Market Facts & Figures by Region
7.2.1 Asia-Pacific Sevoflurane Sales by Region (2020-2031)
7.2.2 Asia-Pacific Sevoflurane Revenue by Region (2020-2031)
7.3 Asia-Pacific Sevoflurane Sales by Type (2020-2025)
7.4 Asia-Pacific Sevoflurane Sales by Application (2020-2025)
8 Europe
8.1 Europe Sevoflurane Market Size YoY Growth 2020-2031
8.2 Europe Sevoflurane Market Facts & Figures by Country
8.2.1 Europe Sevoflurane Sales by Country (2020-2031)
8.2.2 Europe Sevoflurane Revenue by Country (2020-2031)
8.3 Europe Sevoflurane Sales by Type (2020-2025)
8.4 Europe Sevoflurane Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Sevoflurane Market Size YoY Growth 2020-2031
9.2 Latin America Sevoflurane Market Facts & Figures by Country
9.2.1 Latin America Sevoflurane Sales by Country (2020-2031)
9.2.2 Latin America Sevoflurane Revenue by Country (2020-2031)
9.3 Latin America Sevoflurane Sales by Type (2020-2025)
9.4 Latin America Sevoflurane Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Sevoflurane Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Sevoflurane Market Facts & Figures by Country
10.2.1 Middle East and Africa Sevoflurane Sales by Country (2020-2031)
10.2.2 Middle East and Africa Sevoflurane Revenue by Country (2020-2031)
10.3 Middle East and Africa Sevoflurane Sales by Type (2020-2025)
10.4 Middle East and Africa Sevoflurane Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Sevoflurane Supply Chain Analysis
11.2 Sevoflurane Key Raw Materials and Upstream Suppliers
11.3 Sevoflurane Clients Analysis
11.4 Sevoflurane Sales Channel and Sales Model Analysis
11.4.1 Sevoflurane Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Sevoflurane Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Sevoflurane Distributors
12 Sevoflurane Market Dynamics
12.1 Sevoflurane Industry Trends
12.2 Sevoflurane Market Drivers
12.3 Sevoflurane Market Challenges
12.4 Sevoflurane Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Sevoflurane Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Sevoflurane Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Sevoflurane Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Sevoflurane Sales by Region (2020-2025) & (K Units)
Table 5. Global Sevoflurane Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Sevoflurane Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Sevoflurane Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Sevoflurane Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Sevoflurane Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Sevoflurane Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Sevoflurane Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Sevoflurane Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Sevoflurane Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Sevoflurane Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Sevoflurane Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Sevoflurane Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Sevoflurane Sales Share by Manufacturer (2020-2025)
Table 18. Sevoflurane Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Sevoflurane Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Sevoflurane Price (2020-2025) & (US$/Unit)
Table 21. Ranking of Global Top Sevoflurane Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Sevoflurane Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Sevoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane as of 2024)
Table 24. Sevoflurane Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Sevoflurane Market
Table 26. Manufacturers Sevoflurane Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Hengrui Company Information
Table 29. Hengrui Description and Business Overview
Table 30. Hengrui Sevoflurane Product
Table 31. Hengrui Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 32. Hengrui Sales Proportion of Sevoflurane by Product in 2024
Table 33. Hengrui Sales Proportion of Sevoflurane by Application in 2024
Table 34. Hengrui Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 35. Hengrui Recent Developments
Table 36. Baxter Company Information
Table 37. Baxter Description and Business Overview
Table 38. Baxter Sevoflurane Product
Table 39. Baxter Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 40. Baxter Sales Proportion of Sevoflurane by Product in 2024
Table 41. Baxter Sales Proportion of Sevoflurane by Application in 2024
Table 42. Baxter Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 43. Baxter Recent Developments
Table 44. Maruishi Company Information
Table 45. Maruishi Description and Business Overview
Table 46. Maruishi Sevoflurane Product
Table 47. Maruishi Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 48. Maruishi Sales Proportion of Sevoflurane by Product in 2024
Table 49. Maruishi Sales Proportion of Sevoflurane by Application in 2024
Table 50. Maruishi Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 51. Maruishi Recent Developments
Table 52. AbbVie Company Information
Table 53. AbbVie Description and Business Overview
Table 54. AbbVie Sevoflurane Product
Table 55. AbbVie Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. AbbVie Sales Proportion of Sevoflurane by Product in 2024
Table 57. AbbVie Sales Proportion of Sevoflurane by Application in 2024
Table 58. AbbVie Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 59. AbbVie Recent Developments
Table 60. Piramal Company Information
Table 61. Piramal Description and Business Overview
Table 62. Piramal Sevoflurane Product
Table 63. Piramal Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 64. Piramal Sales Proportion of Sevoflurane by Product in 2024
Table 65. Piramal Sales Proportion of Sevoflurane by Application in 2024
Table 66. Piramal Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 67. Piramal Recent Developments
Table 68. Viatris Company Information
Table 69. Viatris Description and Business Overview
Table 70. Viatris Sevoflurane Product
Table 71. Viatris Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Viatris Sales Proportion of Sevoflurane by Product in 2024
Table 73. Viatris Sales Proportion of Sevoflurane by Application in 2024
Table 74. Viatris Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 75. Viatris Recent Developments
Table 76. PT Novell Pharmaceutical Company Information
Table 77. PT Novell Pharmaceutical Description and Business Overview
Table 78. PT Novell Pharmaceutical Sevoflurane Product
Table 79. PT Novell Pharmaceutical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. PT Novell Pharmaceutical Sales Proportion of Sevoflurane by Product in 2024
Table 81. PT Novell Pharmaceutical Sales Proportion of Sevoflurane by Application in 2024
Table 82. PT Novell Pharmaceutical Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 83. PT Novell Pharmaceutical Recent Developments
Table 84. Lunan Pharma Company Information
Table 85. Lunan Pharma Description and Business Overview
Table 86. Lunan Pharma Sevoflurane Product
Table 87. Lunan Pharma Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lunan Pharma Sales Proportion of Sevoflurane by Product in 2024
Table 89. Lunan Pharma Sales Proportion of Sevoflurane by Application in 2024
Table 90. Lunan Pharma Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 91. Lunan Pharma Recent Developments
Table 92. North America Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 93. North America Sevoflurane Sales by Country (2026-2031) & (K Units)
Table 94. North America Sevoflurane Revenue by Country (2020-2025) & (US$ Million)
Table 95. North America Sevoflurane Revenue by Country (2026-2031) & (US$ Million)
Table 96. North America Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 97. North America Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 98. Asia-Pacific Sevoflurane Sales by Region (2020-2025) & (K Units)
Table 99. Asia-Pacific Sevoflurane Sales by Region (2026-2031) & (K Units)
Table 100. Asia-Pacific Sevoflurane Revenue by Region (2020-2025) & (US$ Million)
Table 101. Asia-Pacific Sevoflurane Revenue by Region (2026-2031) & (US$ Million)
Table 102. Asia-Pacific Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 103. Asia-Pacific Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 104. Europe Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 105. Europe Sevoflurane Sales by Country (2026-2031) & (K Units)
Table 106. Europe Sevoflurane Revenue by Country (2020-2025) & (US$ Million)
Table 107. Europe Sevoflurane Revenue by Country (2026-2031) & (US$ Million)
Table 108. Europe Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 109. Europe Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 110. Latin America Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 111. Latin America Sevoflurane Sales by Country (2026-2031) & (K Units)
Table 112. Latin America Sevoflurane Revenue by Country (2020-2025) & (US$ Million)
Table 113. Latin America Sevoflurane Revenue by Country (2026-2031) & (US$ Million)
Table 114. Latin America Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 115. Latin America Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 116. Middle East and Africa Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 117. Middle East and Africa Sevoflurane Sales by Country (2026-2031) & (K Units)
Table 118. Middle East and Africa Sevoflurane Revenue by Country (2020-2025) & (US$ Million)
Table 119. Middle East and Africa Sevoflurane Revenue by Country (2026-2031) & (US$ Million)
Table 120. Middle East and Africa Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 121. Middle East and Africa Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 122. Sevoflurane Key Raw Materials, Industry Status and Trend
Table 123. Sevoflurane Key Raw Materials and Upstream Suppliers
Table 124. Sevoflurane Clients Status and Trend
Table 125. Sevoflurane Typical Clients
Table 126. Sevoflurane Distributors
Table 127. Sevoflurane Market Trends
Table 128. Sevoflurane Market Drivers
Table 129. Sevoflurane Market Challenges
Table 130. Sevoflurane Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Sevoflurane Product Picture
Figure 2. Global Sevoflurane Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Sevoflurane Sales Market Share by Type in 2024 & 2031
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Sevoflurane Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Sevoflurane Sales Market Share by Application in 2024 & 2031
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Other
Figure 11. Sevoflurane Report Years Considered
Figure 12. Global Sevoflurane Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Sevoflurane Market Size 2020-2031 (US$ Million)
Figure 14. Global Sevoflurane Sales 2020-2031 (K Units)
Figure 15. Global Sevoflurane Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Sevoflurane Revenue Market Share by Region (2020-2031)
Figure 17. Global Sevoflurane Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Sevoflurane Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Sevoflurane Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
Figure 20. Global Sevoflurane Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Sevoflurane Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Sevoflurane Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
Figure 23. Generic Drug of Sevoflurane Revenue Market Share by Application, 2024 VS 2031
Figure 24. Original Drug of Sevoflurane Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Sevoflurane Sales Share by Manufacturer in 2024
Figure 26. Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Generic Drug Market Sales Proportion by Manufacturer in 2024
Figure 28. Original Drug Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Sevoflurane Revenue 2020-2031 (US$ Million)
Figure 30. North America Sevoflurane Sales Market Share by Type (2020-2025)
Figure 31. North America Sevoflurane Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Sevoflurane Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Sevoflurane Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Sevoflurane Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Sevoflurane Sales Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Sevoflurane Sales Market Share by Application (2020-2025)
Figure 37. Europe Sevoflurane Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Sevoflurane Sales Market Share by Country (2020-2031)
Figure 39. Europe Sevoflurane Revenue Market Share by Country (2020-2031)
Figure 40. Europe Sevoflurane Sales Market Share by Type (2020-2025)
Figure 41. Europe Sevoflurane Sales Market Share by Application (2020-2025)
Figure 42. Latin America Sevoflurane Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Sevoflurane Sales Market Share by Country (2020-2031)
Figure 44. Latin America Sevoflurane Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Sevoflurane Sales Market Share by Type (2020-2025)
Figure 46. Latin America Sevoflurane Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Sevoflurane Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Sevoflurane Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Sevoflurane Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Sevoflurane Sales Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Sevoflurane Sales Market Share by Application (2020-2025)
Figure 52. Sevoflurane Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Sevoflurane Raw Materials by Region in 2024
Figure 54. Sevoflurane Distribution Channels
Figure 55. Global Sevoflurane Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Sevoflurane Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Sevoflurane Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Sevoflurane Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Sevoflurane Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Sevoflurane Sales by Region (2020-2025) & (K Units)
Table 5. Global Sevoflurane Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Sevoflurane Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Sevoflurane Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Sevoflurane Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Sevoflurane Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Sevoflurane Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Sevoflurane Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Sevoflurane Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Sevoflurane Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Sevoflurane Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Sevoflurane Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Sevoflurane Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Sevoflurane Sales Share by Manufacturer (2020-2025)
Table 18. Sevoflurane Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Sevoflurane Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Sevoflurane Price (2020-2025) & (US$/Unit)
Table 21. Ranking of Global Top Sevoflurane Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Sevoflurane Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Sevoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane as of 2024)
Table 24. Sevoflurane Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Sevoflurane Market
Table 26. Manufacturers Sevoflurane Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Hengrui Company Information
Table 29. Hengrui Description and Business Overview
Table 30. Hengrui Sevoflurane Product
Table 31. Hengrui Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 32. Hengrui Sales Proportion of Sevoflurane by Product in 2024
Table 33. Hengrui Sales Proportion of Sevoflurane by Application in 2024
Table 34. Hengrui Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 35. Hengrui Recent Developments
Table 36. Baxter Company Information
Table 37. Baxter Description and Business Overview
Table 38. Baxter Sevoflurane Product
Table 39. Baxter Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 40. Baxter Sales Proportion of Sevoflurane by Product in 2024
Table 41. Baxter Sales Proportion of Sevoflurane by Application in 2024
Table 42. Baxter Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 43. Baxter Recent Developments
Table 44. Maruishi Company Information
Table 45. Maruishi Description and Business Overview
Table 46. Maruishi Sevoflurane Product
Table 47. Maruishi Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 48. Maruishi Sales Proportion of Sevoflurane by Product in 2024
Table 49. Maruishi Sales Proportion of Sevoflurane by Application in 2024
Table 50. Maruishi Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 51. Maruishi Recent Developments
Table 52. AbbVie Company Information
Table 53. AbbVie Description and Business Overview
Table 54. AbbVie Sevoflurane Product
Table 55. AbbVie Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. AbbVie Sales Proportion of Sevoflurane by Product in 2024
Table 57. AbbVie Sales Proportion of Sevoflurane by Application in 2024
Table 58. AbbVie Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 59. AbbVie Recent Developments
Table 60. Piramal Company Information
Table 61. Piramal Description and Business Overview
Table 62. Piramal Sevoflurane Product
Table 63. Piramal Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 64. Piramal Sales Proportion of Sevoflurane by Product in 2024
Table 65. Piramal Sales Proportion of Sevoflurane by Application in 2024
Table 66. Piramal Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 67. Piramal Recent Developments
Table 68. Viatris Company Information
Table 69. Viatris Description and Business Overview
Table 70. Viatris Sevoflurane Product
Table 71. Viatris Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Viatris Sales Proportion of Sevoflurane by Product in 2024
Table 73. Viatris Sales Proportion of Sevoflurane by Application in 2024
Table 74. Viatris Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 75. Viatris Recent Developments
Table 76. PT Novell Pharmaceutical Company Information
Table 77. PT Novell Pharmaceutical Description and Business Overview
Table 78. PT Novell Pharmaceutical Sevoflurane Product
Table 79. PT Novell Pharmaceutical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. PT Novell Pharmaceutical Sales Proportion of Sevoflurane by Product in 2024
Table 81. PT Novell Pharmaceutical Sales Proportion of Sevoflurane by Application in 2024
Table 82. PT Novell Pharmaceutical Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 83. PT Novell Pharmaceutical Recent Developments
Table 84. Lunan Pharma Company Information
Table 85. Lunan Pharma Description and Business Overview
Table 86. Lunan Pharma Sevoflurane Product
Table 87. Lunan Pharma Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lunan Pharma Sales Proportion of Sevoflurane by Product in 2024
Table 89. Lunan Pharma Sales Proportion of Sevoflurane by Application in 2024
Table 90. Lunan Pharma Sales Proportion of Sevoflurane by Geographic Area in 2024
Table 91. Lunan Pharma Recent Developments
Table 92. North America Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 93. North America Sevoflurane Sales by Country (2026-2031) & (K Units)
Table 94. North America Sevoflurane Revenue by Country (2020-2025) & (US$ Million)
Table 95. North America Sevoflurane Revenue by Country (2026-2031) & (US$ Million)
Table 96. North America Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 97. North America Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 98. Asia-Pacific Sevoflurane Sales by Region (2020-2025) & (K Units)
Table 99. Asia-Pacific Sevoflurane Sales by Region (2026-2031) & (K Units)
Table 100. Asia-Pacific Sevoflurane Revenue by Region (2020-2025) & (US$ Million)
Table 101. Asia-Pacific Sevoflurane Revenue by Region (2026-2031) & (US$ Million)
Table 102. Asia-Pacific Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 103. Asia-Pacific Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 104. Europe Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 105. Europe Sevoflurane Sales by Country (2026-2031) & (K Units)
Table 106. Europe Sevoflurane Revenue by Country (2020-2025) & (US$ Million)
Table 107. Europe Sevoflurane Revenue by Country (2026-2031) & (US$ Million)
Table 108. Europe Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 109. Europe Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 110. Latin America Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 111. Latin America Sevoflurane Sales by Country (2026-2031) & (K Units)
Table 112. Latin America Sevoflurane Revenue by Country (2020-2025) & (US$ Million)
Table 113. Latin America Sevoflurane Revenue by Country (2026-2031) & (US$ Million)
Table 114. Latin America Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 115. Latin America Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 116. Middle East and Africa Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 117. Middle East and Africa Sevoflurane Sales by Country (2026-2031) & (K Units)
Table 118. Middle East and Africa Sevoflurane Revenue by Country (2020-2025) & (US$ Million)
Table 119. Middle East and Africa Sevoflurane Revenue by Country (2026-2031) & (US$ Million)
Table 120. Middle East and Africa Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 121. Middle East and Africa Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 122. Sevoflurane Key Raw Materials, Industry Status and Trend
Table 123. Sevoflurane Key Raw Materials and Upstream Suppliers
Table 124. Sevoflurane Clients Status and Trend
Table 125. Sevoflurane Typical Clients
Table 126. Sevoflurane Distributors
Table 127. Sevoflurane Market Trends
Table 128. Sevoflurane Market Drivers
Table 129. Sevoflurane Market Challenges
Table 130. Sevoflurane Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Sevoflurane Product Picture
Figure 2. Global Sevoflurane Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Sevoflurane Sales Market Share by Type in 2024 & 2031
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Sevoflurane Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Sevoflurane Sales Market Share by Application in 2024 & 2031
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Other
Figure 11. Sevoflurane Report Years Considered
Figure 12. Global Sevoflurane Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Sevoflurane Market Size 2020-2031 (US$ Million)
Figure 14. Global Sevoflurane Sales 2020-2031 (K Units)
Figure 15. Global Sevoflurane Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Sevoflurane Revenue Market Share by Region (2020-2031)
Figure 17. Global Sevoflurane Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Sevoflurane Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Sevoflurane Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
Figure 20. Global Sevoflurane Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Sevoflurane Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Sevoflurane Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
Figure 23. Generic Drug of Sevoflurane Revenue Market Share by Application, 2024 VS 2031
Figure 24. Original Drug of Sevoflurane Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Sevoflurane Sales Share by Manufacturer in 2024
Figure 26. Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Generic Drug Market Sales Proportion by Manufacturer in 2024
Figure 28. Original Drug Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Sevoflurane Revenue 2020-2031 (US$ Million)
Figure 30. North America Sevoflurane Sales Market Share by Type (2020-2025)
Figure 31. North America Sevoflurane Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Sevoflurane Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Sevoflurane Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Sevoflurane Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Sevoflurane Sales Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Sevoflurane Sales Market Share by Application (2020-2025)
Figure 37. Europe Sevoflurane Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Sevoflurane Sales Market Share by Country (2020-2031)
Figure 39. Europe Sevoflurane Revenue Market Share by Country (2020-2031)
Figure 40. Europe Sevoflurane Sales Market Share by Type (2020-2025)
Figure 41. Europe Sevoflurane Sales Market Share by Application (2020-2025)
Figure 42. Latin America Sevoflurane Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Sevoflurane Sales Market Share by Country (2020-2031)
Figure 44. Latin America Sevoflurane Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Sevoflurane Sales Market Share by Type (2020-2025)
Figure 46. Latin America Sevoflurane Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Sevoflurane Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Sevoflurane Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Sevoflurane Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Sevoflurane Sales Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Sevoflurane Sales Market Share by Application (2020-2025)
Figure 52. Sevoflurane Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Sevoflurane Raw Materials by Region in 2024
Figure 54. Sevoflurane Distribution Channels
Figure 55. Global Sevoflurane Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Sevoflurane Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232